Publikationen

Hier finden Sie ausgewählte Publikationen zur Gynäkologie:

Wolters R, Wischhusen J, Stüber T, Weiss CR, Krockberger M, Bartmann C, Blettner M, Janni W, Kreienberg R, Schwentner L, Novopashenny I, Wischnewsky M, Wöckel A, Diessner J (2015) Guidelines are advantageous, though not essential for improved survival among breast cancer patients. Breast Cancer Res Treat 152:357-66.

Wöckel A, Janni W, Porzsolt F, Schmutzler R (2014) Benefits and risks of breast cancer screening. Oncol Res Treat 37 Suppl 3:21-8.

Herr D, Bekes I, Wulff C (2015) Regulation of endothelial permeability in the primate corpora lutea: implications for ovarian hyperstimulation syndrome. Reproduction 149:R71-9.

Bartmann C, Segerer SE, Rieger L, Kapp M, Sütterlin M, Kämmerer U (2014) Quantification of the predominant immune cell populations in decidua throughout human pregnancy. Am J Reprod Immunol 71:109-19.

Häusler SF, Del Barrio IM, Diessner J, Stein RG, Strohschein J, Hönig A, Dietl J, Wischhusen J (2014) Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion. Am J Transl Res 6:129-39.

Publikationen 2015

Diessner J, Van Ewijk R, Weiss CR, Janni W, Wischnewsky MB, Kreienberg R, Hancke K, Blettner M, Wöckel A, Schwentner L. (2015) Identifying the impact of inflammatory breast cancer on survival: a retrospective multi-center cohort study. Arch Gynecol Obstet 292(3):655-64.

Dietl A, Cupisti S, Beckmann MW, Schwab M, Zollner U. (2015) Pregnancy and Obstetrical Outcomes in Women Over 40 Years of Age. Geburtsh Frauenheilk 75(8):827-832.

Ebner F, Hancke K, Blettner M, Schwentner L, Wöckel A, Kreienberg R, Janni W, van Ewijk R. (2015) Aggressive Intrinsic Subtypes in Breast Cancer: A Predictor of Guideline Adherence in Older Patients With Breast Cancer? Clin Breast Cancer 15(4):e189-95.

Ebner F, van Ewijk R, Wöckel A, Hancke K, Schwentner L, Fink V, Kreienberg R, Janni W, Blettner M. (2015) Tumor biology in older breast cancer patients--what is the impact on survival stratified for guideline adherence? A retrospective multi-centre cohort study of 5378 patients. Breast 24(3):256-62.

Ebner F, Varga D, Sorg F, Vorwerk E, Schochter F, Janni W, Wöckel A, DeGregorio N. (2015) Treatment cost evaluation of extrauterine gravidity: a literature review of medical and surgical treatment costs. Arch Gynecol Obstet 291(3):493-8.

Frauenschuh I, Wirbelauer J, Karl S, Girschick G, Rehn M, Zollner U, Frambach T, Dietl J, Müller T. (2015) Prognostic factors of perinatal short-term outcome in severe placental insufficiency using Doppler sonography to assess end-diastolic absent and reverse blood flow in umbilical arteries. Z Geburtshilfe Neonatol 219(1):28-36.

Hahne JC, Kurz A, Meyer SR, Dietl J, Engel JB, Honig A. (2015) Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS-126 in models of ovarian cancer. Arch Gynecol Obstet 291(1):131-41.

Harter PN, Bernatz S, Scholz A, Zeiner PS, Zinke J, Kiyose M, Blasel S, Beschorner R, Senft C, Bender B, Ronellenfitsch MW, Wikman H, Glatzel M, Meinhardt M, Juratli TA, Steinbach JP, Plate KH, Wischhusen J, Weide B, Mittelbronn M. (2015) Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases. Oncotarget 6(38):40836-49.

Heinrich T, Nanda I, Rehn M, Zollner U, Ernestus K, Wirth C, Schlüter G, Schmid M, Kunstmann E. (2015) Co-Occurence of Reciprocal Translocation and COL2A1 Mutation in a Fetus with Severe Skeletal Dysplasia: Implications for Genetic Counseling. Cytogenet Genome Res 145(1):25-8.

Herr D, Bekes I, Wulff C. (2015) Regulation of endothelial permeability in the primate corpora lutea: implications for ovarian hyperstimulation syndrome. Reproduction 149(2):R71-9.

Hummel J, Kämmerer U, Müller N, Avota E, Schneider-Schaulies S. (2015) Human endogenous retrovirus envelope proteins target dendritic cells to suppress T-cell activation. Eur J Immunol 45(6):1748-59.

Jokinen J, Adametz V, Kredel M, Muellenbach RM, Hönig A, Wöckel A, Dietl J, Roewer N, Kranke P. (2015) Spinal anesthesia in high-volume, low-concentration technique for Caesarean sections: Retrospective analysis. Anaesthesist 164(2):108-14.

Kämmerer U, Gires O, Pfetzer N, Wiegering A, Klement RJ, Otto C. (2015) TKTL1 expression in human malign and benign cell lines. BMC Cancer 15:2.

Kumar P, Naumann U, Aigner L, Wischhusen J, Beier CP, Beier D. (2015) Impaired TGF-? induced growth inhibition contributes to the increased proliferation rate of neural stem cells harboring mutant p53. Am J Cancer Res 5(11):3436-45.

Lutz M, Worschech A, Alb M, Gahn S, Bernhard L, Schwab M, Obermeier S, Einsele H, Kämmerer U, Heuschmann P, Klinker E, Otto C, Mielke S. (2015) Boost and loss of immune responses against tumor-associated antigens in the course of pregnancy as a model for allogeneic immunotherapy. Blood 125(2):261-72.

Mariz K, Ingolf JB, Daniel H, Teresa NJ, Erich-Franz S. (2015) The Wnt inhibitor dickkopf-1: a link between breast cancer and bone metastases. Clin Exp Metastasis 32(8):857-66.

Müller T, Wirbelauer J, Frauenschuh I, Frambach T, Zollner U, Dietl J. (2015) Umbilical Absent and Reverse End-Diastolic Flow Velocity Waveforms Already Present Prior to Viability do not Exclude Long-Term Foetal Surveillance: A Report of Two Cases. Z Geburtshilfe Neonatol 219(2):99-101.

Schmitt J, Eckardt S, Schlegel PG, Sirén AL, Bruttel VS, McLaughlin KJ, Wischhusen J, Müller AM. (2015) Human Parthenogenetic Embryonic Stem Cell-Derived Neural Stem Cells Express HLA-G and Show Unique Resistance to NK Cell-Mediated Killing. Mol Med 21:185-96.

Singer S, Blettner M, Kreienberg R, Janni W, Wöckel A, Kühn T, Felberbaum R, Flock F, Schwentner L, BRENDA II study group. (2015) Breast Cancer Patients' Fear of Treatment: Results from the Multicenter Longitudinal Study BRENDA II. Breast Care 10(2):95-100.

Stüber TN, Künzel EC, Zollner U, Rehn M, Wöckel A, Hönig A. (2015) Prevalence and Associated Risk Factors for Obesity During Pregnancy Over Time. Geburtsh Frauenheilk 75(9):923-928.

Van Ewijk R, Wöckel A, Gundelach T, Hancke K, Janni W, Singer S, Kreienberg R, Blettner M, Schwentner L. (2015) Is guideline-adherent adjuvant treatment an equal alternative for patients aged >65 who cannot participate in adjuvant clinical breast cancer trials? A retrospective multi-center cohort study of 4,142 patients. Arch Gynecol Obstet 291(3):631-40.

Varagnolo L, Lin Q, Obier N, Plass C, Dietl J, Zenke M, Claus R, Müller AM. (2015) PRC2 inhibition counteracts the culture-associated loss of engraftment potential of human cord blood-derived hematopoietic stem and progenitor cells. Sci Rep 5:12319.

Wolters R, Wischhusen J, Stüber T, Weiss CR, Krockberger M, Bartmann C, Blettner M, Janni W, Kreienberg R, Schwentner L, Novopashenny I, Wischnewsky M, Wöckel A, Diessner J. (2015) Guidelines are advantageous, though not essential for improved survival among breast cancer patients. Breast Cancer Res Treat 152(2):357-66.

Zeiner PS, Preusse C, Blank AE, Zachskorn C, Baumgarten P, Caspary L, Braczynski AK, Weissenberger J, Bratzke H, Reiß S, Pennartz S, Winkelmann R, Senft C, Plate KH, Wischhusen J, Stenzel W, Harter PN, Mittelbronn M. (2015) MIF Receptor CD74 is Restricted to Microglia/Macrophages, Associated with a M1-Polarized Immune Milieu and Prolonged Patient Survival in Gliomas. Brain Pathol 25(4):491-504.

Publikationen 2014

Bartmann C, Segerer SE, Rieger L, Kapp M, Sütterlin M, Kämmerer U. (2014) Quantification of the predominant immune cell populations in decidua throughout human pregnancy. Am J Reprod Immunol 71(2):109-19.

Chandran PA, Keller A, Weinmann L, Adel Seida A, Braun M, Andreev K, Fischer B, Horn E, Schwinn S, Junker M, Houben R, Dombrowski Y, Dietl J, Finotto S, Wölfl M, Meister G, Wischhusen J. (2014) The TGF-?-inducible miR-23a cluster attenuates IFN-? levels and antigen-specific cytotoxicity in human CD8+ T cells. J Leukoc Biol 96(4):633-45.

Diessner J, Bruttel V, Stein RG, Horn E, Häusler SF, Dietl J, Hönig A, Wischhusen J. (2014) Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1). Cell Death Dis 5:e1149.

Dietl J. (2014) Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube. Arch Gynecol Obstet 289(2):241-6.

Ebner F, deGregorio N, Vorwerk E, Janni W, Wöckel A, Varga D. (2014) Should a drain be placed in early breast cancer surgery? Breat Care 9(2):116-22.

Engel JB, Honig A, Kapp M, Hahne JC, Meyer SR, Dietl J, Segerer SE. (2014) Mechanisms of tumor immune escape in triple-negative breast cancers (TNBC) with and without mutated BRCA 1. Arch Gynecol Obstet 289(1):141-7.

Frauenschuh I, Frambach T, Karl S, Dietl J, Müller T. (2014) Ductus venosus blood flow prior to intrauterine foetal death in severe placental insufficiency can be unaffected as shown by doppler sonography. Z Geburtshilfe Neonatol 218(5):218-22.

Hahne JC, Meyer SR, Dietl J, Honig A. (2014) The effect of Cordyceps extract and a mixture of Ganoderma lucidum/Agaricus Blazi Murill extract on human endometrial cancer cell lines in vitro. Int J Oncol 45(1):373-82.

Häusler SF, Del Barrio IM, Diessner J, Stein RG, Strohschein J, Hönig A, Dietl J, Wischhusen J. (2014) Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion. Am J Transl Res 6(2):129-39.

Keller A, Leidinger P, Vogel B, Backes C, ElSharawy A, Galata V, Mueller SC, Marquart S, Schrauder MG, Strick R, Bauer A, Wischhusen J, Beier M, Kohlhaas J, Katus HA, Hoheisel J, Franke A, Meder B, Meese E. (2014) miRNAs can be generally associated with human pathologies as exemplified for miR-144. BMC Med 12(1):224.

Knieper C, Ramsauer B, Hancke K, Woeckel A, Ismail L, Bühren A, Toth B. (2014) "Pregnant and Operating": Evaluation of a Germany-wide Survey Among Female Gynaecologists and Surgeons. Geburtsh Frauenheilk 74(9):875-880.

Rieger J, Bähr O, Maurer GD, Hattingen E, Franz K, Brucker D, Walenta S, Kämmerer U, Coy JF, Weller M, Steinbach JP. (2014) ERGO: a pilot study of ketogenic diet in recurrent glioblastoma. Int J Oncol 44(6):1843-52.

Siegl C, Prusty BK, Karunakaran K, Wischhusen J, Rudel T. (2014) Tumor suppressor p53 alters host cell metabolism to Limit Chlamydia trachomatis infection. Cell Rep 9(3):918-29.

Stein RG, Meinusch M, Diessner J, Dietl J, Hönig A, Zollner U. (2014) Amniotic fluid insulin and C-peptide as predictive markers for fetal macrosomia, birth injuries, and delivery complications? Med Sci Monit 20:54-8.

Wiegering A, Korb D, Thalheimer A, Kämmerer U, Allmanritter J, Matthes N, Linnebacher M, Schlegel N, Klein I, Ergün S, Germer CT, Otto C. (2014) E7080 (lenvatinib), a multi-targeted tyrosine kinase inhibitor, demonstrates antitumor activities against colorectal cancer xenografts. Neoplasia 16(11):972-81.

Publikationen 2013

Dent S, Oyan B, Honig A, Mano M, Howell S. (2013) HER2-targeted therapy in breast cancer: a systematic review of neoadjuvant trials. Cancer Treat Rev 39(6):622-31.

Diessner J, Bruttel V, Becker K, Pawlik M, Stein R, Häusler S, Dietl J, Wischhusen J, Hönig A. (2013) Targeting breast cancer stem cells with HER2-specific antibodies and natural killer cells. Am J Cancer Res 3(2):211-20.

Diessner J, Stüber T, Niederle B, Pawlik M, Dietl J, Honig A. (2013) XY gonadal dysgenesis--development of a germ cell tumor: case report. Eur J Gynaecol Oncol 34(6):572-4.

Hahne JC, Meyer SR, Gambaryan S, Walter U, Dietl J, Engel JB, Honig A. (2013) Immune escape of AKT overexpressing ovarian cancer cells. Int J Oncol 42(5):1630-5.

Hahne JC, Meyer SR, Kranke P, Dietl J, Guckenberger M, Polat B, Hönig A. (2013) Studies on the role of osteopontin-1 in endometrial cancer cell lines. Strahlenther Onkol 178(12):1040-8.

Hahne JC, Schmidt H, Meyer SR, Engel JB, Dietl J, Honig A. (2013) Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS 126 in models of triple-negative breast cancer. J Cancer Res Clin Oncol 139(6):905-14.

Hennicke F, Grumbt M, Lermann U, Ueberschaar N, Palige K, Böttcher B, Jacobsen ID, Staib C, Morschhäuser J, Monod M, Hube B, Hertweck C, Staib P. (2013) Factors supporting cysteine tolerance and sulfite production in Candida albicans. Eukaryot Cell 12(4):604-13.

Hölters S, Anacker J, Jansen L, Beer-Grondke K, Dürst M, Rubio I. (2013) Tetraspanin 1 promotes invasiveness of cervical cancer cells. Int J Oncol 43(2):503-12.

Klotz D, Frölich K, Zollner U, Rehn M, Wirbelauer J. (2013) Unexpected respiratory distress in the delivery room--a rare differential diagnosis for the obstetrician and neonatologist. Z Geburtshilfe Neonatol 217(4):144-6.

Kranke P, Girard T, Lavand'homme P, Melber A, Jokinen J, Muellenbach RM, Wirbelauer J, Hönig A. (2013) Must we press on until a young mother dies? Remifentanil patient controlled analgesia in labour may not be suited as a "poor man's epidural". BMC Pregnancy Childbirth 13:139.

Palige K, Linde J, Martin R, Böttcher B, Citiulo F, Sullivan DJ, Weber J, Staib C, Rupp S, Hube B, Morschhäuser J, Staib P. (2013) Global transcriptome sequencing identifies chlamydospore specific markers in Candida albicans and Candida dubliniensis. PLoS ONE 18(4):e61940.

Segerer SE, Martignoni F, Bogdan A, Müller N, Kapp M, Dietl J, Rieger L, Kämmerer U. (2013) Thrombopoietin modulates the proliferation, migration and cytokine profile of decidual cell subsets during early gestation. Mol Hum Reprod 19(6):361-8.

Wasem S, Rifai M, Hönig A, Wirbelauer J, Roewer N, Kranke P. (2013) Should opioids be routinely used for the induction of general anaesthesia for caesarean section? Anasthesiol Intensivmed Notfallmed Schmerzther 48(6):374-7.

Zollner KP, Hofmann T, Zollner U. (2013) Good fertilization results associated with high IL-1beta concentrations in follicular fluid of IVF patients. J Reprod Med 58(11-12):485-90.

Zollner U, Dietl J. (2013) Perinatal risks after IVF and ICSI. J Perinat Med 41(1):17-22.

Zollner U, Neumann C, Zollner KP. (2013) Probability of success of conservative treatment of infertility: exact timing as an important prognostic factor. J Reprod Med 58(5-6):205-11.

Publikationen 2012

Bauer B, Majic M, Rauthe S, Bröcker EB, Kerstan A. (2012) Persistent swelling after flushing of an abscess with Octenisept®. Unfallchirurg 115(12):1116-9.

Beier CP, Kumar P, Meyer K, Leukel P, Bruttel V, Aschenbrenner I, Riemenschneider MJ, Fragoulis A, Rümmele P, Lamszus K, Schulz JB, Weis J, Bogdahn U, Wischhusen J, Hau P, Spang R, Beier D. (2012) The cancer stem cell subtype determines immune infiltration of glioblastoma. Stem Cells Dev 21(15):2753-61.

Engel JB, Hahne JC, Häusler SF, Meyer S, Segerer SE, Diessner J, Dietl J, Honig A. (2012) Peptidomimetic GnRH antagonist AEZS-115 inhibits the growth of ovarian and endometrial cancer cells. Anticancer Res 32(5):2063-8.

Engel JB, Martens T, Hahne JC, Häusler SF, Krockenberger M, Segerer S, Djakovic A, Meyer S, Dietl J, Wischhusen J, Honig A. (2012) Effects of lobaplatin as a single agent and in combination with TRAIL on the growth of triple-negative p53-mutated breast cancers in vitro. Anticancer Drugs 23(4):426-36.

Hahne JC, Honig A, Meyer SR, Gambaryan S, Walter U, Wischhusen J, Häussler SF, Segerer SE, Fujita N, Dietl J, Engel JB. (2012) Downregulation of AKT reverses platinum resistance of human ovarian cancers in vitro. Oncol Rep 28(6):2023-8.

Hassold N, Seystahl K, Kempf K, Urlaub D, Zekl M, Einsele H, Watzl C, Wischhusen J, Seggewiss-Bernhardt R. (2012) Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by dasatinib. Int J Cancer131(6):E916-27.

Häusler SF, Bernar T, Rau S, Kranke P, Dietl J, Rieger L. (2012) Severe maternal hepatopathies in the peripartum period--a case series with review of the literature focusing on pathogenesis and differential diagnosis. Z Geburtshilfe Neonatol 216(6):277-84.

Honig A, Hahne JC, Meyer S, Kranke P, Häusler S, Diessner J, Dietl J, Engel JB. (2012) PI3K inhibitor D-116883 is effective in in vitro models of ovarian cancer. Anticancer Res 32(5):2035-41.

Klingelhoeffer C, Kämmerer U, Koospal M, Mühling B, Schneider M, Kapp M, Kübler A, Germer CT, Otto C. (2012) Natural resistance to ascorbic acid induced oxidative stress is mainly mediated by catalase activity in human cancer cells and catalase-silencing sensitizes to oxidative stress. BMC Complement Altern Med 12:61.

Krockenberger M, Kranke P, Häusler S, Engel JB, Horn E, Nürnberger K, Wischhusen J, Dietl J, Hönig A. (2012) Macrophage migration-inhibitory factor levels in serum of patients with ovarian cancer correlates with poor prognosis. Anticancer Res 32(12):5233-8.

Segerer SE, Rieger L, Kapp M, Dombrowski Y, Müller N, Dietl J, Kämmerer U. (2012) MIC-1 (a multifunctional modulator of dendritic cell phenotype and function) is produced by decidual stromal cells and trophoblasts. Hum Reprod 27(1):200-9.

Segerer SE, Staib C, Kaemmerer U, Frambach T, Honig A, Dietl J, Rieger L. (2012) Dendritic cells: elegant arbiters in human reproduction. Curr Pharm Biotechnol 13(8):1378-84.

Stein RG, Diessner J, Frieauff E, Zollner U, Rehn M, Dietl J, Hönig A. (2012) Acute foeto-foetal transfusion syndrome--case report and review of the literature. Z Geburtshilfe Neonatol 216(3):147-9.

Zollner U, Rehn M, Girschick G, Dietl J. (2012) Sonographic abnormalities of the fetal CNS in the second trimester screening--clarifications according to the new maternity directives. Z Geburtshilfe Neonatol 216(1):1-10.

Zollner U, Rehn M, Heuer S, Morr AK, Dietl J. (2012) Umbilical cord entanglement in monoamniotic twins. Ultrasound Obstet Gynecol 40(1):121-2.

Zollner U, Specketer MT, Dietl J, Zollner KP. (2012) 3D-Endometrial volume and outcome of cryopreserved embryo replacement cycles. Arch Gynecol Obstet 286(2):517-23.

Publikationen 2011

Ahles A, Rochais F, Frambach T, Bünemann M, Engelhardt S. (2011) A polymorphism-specific "memory" mechanism in the ?(2)-adrenergic receptor. Sci Signal 4(185):ra53.

Anacker J, Segerer SE, Hagemann C, Feix S, Kapp M, Bausch R, Kämmerer U. (2011) Human decidua and invasive trophoblasts are rich sources of nearly all human matrix metalloproteinases. Mol Hum Reprod 17(10):637-52.

Boussaad I, Varagnolo L, Hornich V, Rieger L, Krockenberger M, Stuehmer T, Kranzfelder D, Mueller AM, Schneider-Schaulies S. (2011) Wild-type measles virus interferes with short-term engraftment of human CD34+ hematopoietic progenitor cells. J Virol 85(15):7710-8.

Dietl J, Wischhusen J, Häusler SF. (2011) The post-reproductive Fallopian tube: better removed? Hum Reprod 26(11):2918-24.

Dietl J. (2011) Is lymphadenectomy justified in endometrial cancer? Int J Gynecol Cancer 21(3):507-10.

Djakovic A, Engel JB, Geisinger E, Honig A, Tschammler A, Dietl J. (2011) Pleomorphic adenoma of the breast initially misdiagnosed as metaplastic carcinoma in preoperative stereotactic biopsy: a case report and review of the literature. Eur J Gynaecol Oncol 32(4):427-30.

Engel JB, Schönhals T, Häusler S, Krockenberger M, Schmidt M, Horn E, Köster F, Dietl J, Wischhusen J, Honig A. (2011) Induction of programmed cell death by inhibition of AKT with the alkylphosphocholine perifosine in in vitro models of platinum sensitive and resistant ovarian cancers. Arch Gynecol Obstet 283(3):603-10.

Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S. (2011) Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric st. Fertil Steril 95(6):2029-33, 2033.e1.

Hagemann C, Weigelin B, Schommer S, Schulze M, Al-Jomah N, Anacker J, Gerngras S, Kühnel S, Kessler AF, Polat B, Ernestus RI, Patel R, Vince GH. (2011) The cohesin-interacting protein, precocious dissociation of sisters 5A/sister chromatid cohesion protein 112, is up-regulated in human astrocytic tumors. Int J Mol Med 27(1):39-51.

Hahne JC, Fuchs T, Florin A, Edwards D, Pourtier A, Soncin F, Wernert N. (2011) Evaluation of effects caused by differentially spliced Ets-1 transcripts in fibroblasts. Int J Oncol 39(5):1073-82.

Hahne JC, Okuducu AF, Fuchs T, Florin A, Wernert N. (2011) Identification of ETS-1 target genes in human fibroblasts. Int J Oncol. 38(6):1645-52.

Häusler SF, Montalbán del Barrio I, Strohschein J, Anoop Chandran P, Engel JB, Hönig A, Ossadnik M, Horn E, Fischer B, Krockenberger M, Heuer S, Seida AA, Junker M, Kneitz H, Kloor D, Klotz KN, Dietl J, Wischhusen J. (2011) Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity. Cancer Immunol Immunother 60(10):1405-18.

Houben R, Hesbacher S, Schmid CP, Kauczok CS, Flohr U, Haferkamp S, Müller CS, Schrama D, Wischhusen J, Becker JC. (2011) High-level expression of wild-type p53 in melanoma cells is frequently associated with inactivity in p53 reporter gene assays. PLoS ONE 6(7):e22096.

Kämmerer U, Germeyer A, Stengel S, Kapp M, Denner J. (2011) Human endogenous retrovirus K (HERV-K) is expressed in villous and extravillous cytotrophoblast cells of the human placenta.Human endogenous retrovirus K (HERV-K) is expressed in villous and extravillous cytotrophoblast cells of the human placenta. J Reprod Immunol 91(1-2): 1-8.

Keller A, Leidinger P, Bauer A, Elsharawy A, Haas J, Backes C, Wendschlag A, Giese N, Tjaden C, Ott K, Werner J, Hackert T, Ruprecht K, Huwer H, Huebers J, Jacobs G, Rosenstiel P, Dommisch H, Schaefer A, Müller-Quernheim J, Wullich B, Keck B, Graf N, Reichrath J, Vogel B, Nebel A, Jager SU, Staehler P, Amarantos I, Boisguerin V, Staehler C, Beier M, Scheffler M, Büchler MW, Wischhusen J, Haeusler SF, Dietl J, Hofmann S, Lenhof HP, Schreiber S, Katus HA, Rottbauer W, Meder B, Hoheisel JD, Franke A, Meese E. (2011)

Klement RJ, Kämmerer U. (2011) Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr Metab (Lond) 8:75.

Kranke P, Frambach T, Schelling P, Wirbelauer J, Schaefer C, Stamer U. (2011) Anaesthesia and breast-feeding: should breast-feeding be discouraged? Anasthesiol Intensivmed Notfallmed Schmerzther. 46(5):304-11.

Mittelbronn M, Platten M, Zeiner P, Dombrowski Y, Frank B, Zachskorn C, Harter PN, Weller M, Wischhusen J. (2011) Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression. Acta Neuropathol (Berl) 122(3):353-65.

Niederle B, Rauthe S, Engel JB, Krockenberger M, Dietl J, Honig A. (2011) Papillary squamotransitional cell carcinoma of the vagina. J Obstet Gynaecol Res 37(12):1851-5.

Rennemeier C, Schwab M, Lermann U, Albert C, Kämmerer U, Frambach T, Morschhäuser J, Dietl J, Staib P. (2011) Seminal plasma protects human spermatozoa and pathogenic yeasts from capture by dendritic cells. Hum Reprod 26(5):987-99.

Roth P, Wischhusen J, Happold C, Chandran PA, Hofer S, Eisele G, Weller M, Keller A. (2011) A specific miRNA signature in the peripheral blood of glioblastoma patients. J Neurochem 118(3):449-57.

Rüsch D, Becke K, Eberhart LH, Franck M, Hönig A, Morin AM, Opel S, Piper S, Treiber H, Ullrich L, Wallenborn J, Kranke P. (2011) Postoperative nausea and vomiting (PONV) - recommendations for risk assessment, prophylaxis and therapy - results of an expert panel meeting. Anasthesiol Intensivmed Notfallmed Schmerzther 46(3):158-70.

Schmidt M, Pfetzer N, Schwab M, Strauss I, Kämmerer U. (2011) Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial. Nutr Metab (Lond) 8(1):54.

Schnabel A, Hahn N, Muellenbach R, Frambach T, Hoenig A, Roewer N, Kranke P. (2011) Obstetric analgesia in German clinics. Remifentanil as alternative to regional analgesia. Anaesthesist 60(11):995-1001.

Toth B, Segerer S, Solano ME, Nevers T, Baumann K, Gueuvoghlanian-Silva BY, Jago C, Scholz C. (2011) Fostering new investigators in Reproductive Immunology. J Reprod Immunol 90(1):124-6.

Kontakt, Öffnungszeiten, Sprechzeiten

Sprechzeiten Privatsprechstunde:

Montag 09:30 Uhr bis 12:30 Uhr
Mittwoch 09:30 Uhr bis 12:30 Uhr
sowie nach Vereinbarung

weitere Sprechzeiten siehe Schwerpunkte oder Ambulante Behandlung

Telefon:

Auskunft / Pforte:
+49 931 201-25253 oder
+49 931 201-25621

Fax:

+49 931 201-25258


Anschrift:

Frauenklinik und Poliklinik des Universitätsklinikums | Josef-Schneider-Str. 4 | Haus C15 | 97080 Würzburg | Deutschland